Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
636.00    -43.00 (-6.33%)
Bid:
636.00
Ask:
638.00
Spread: 2.00 (0.314%)
Market Cap: £1.17b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Trading Update

28 Mar 2019 07:00

RNS Number : 2401U
Volex PLC
28 March 2019
Β 

28 March 2019

Β 

Volex plc

("Volex" or the "Company")

Β 

Trading Update

Β 

Volex plc, the global provider of cable assemblies, issues the following trading update ahead of the announcement on 13 June 2019 of its full-year results for the year ended 31 March 2019.

Β 

Β· Trading continues to be ahead of market expectations across the group, with the three acquisitions made during the year all performing to plan

Β 

Β· Full-year sales expected to exceed $365 million (2017/18: $322 million)

Β 

Β· Cash as at 22 March 2019 of $18.4 million compares with $24.9 million reported at the half year. Volex invested $16.5 million into the acquisition of GTK and related costs in December 2018, and has therefore generated $10.0 million of net free cash flow over the second half of the year

Β 

Β· Volex intends to resume the payment of a dividend in respect of the 2019/20 financial year assuming trading continues to perform in line with our expectations and no material acquisitions are made during the period

Β 

Nat Rothschild, Executive Chairman of Volex, commented:

Β 

"As announced at the time of the first-half results in November 2018, competition continued to be intense in the second half, and cost inflation hasΒ continuedΒ across both our raw material and labour cost lines. However, Volex has again produced a solid performance in both sales and operating margins. There remain substantial identifiable opportunities for both divisions to improve sales and margin performance through disciplined execution of our strategy, in both the short and longer term, and we expect to deliver a robustΒ trading performance for the full year, ahead of the Board's expectations. The Board remains excited about the Company's ability to drive shareholder value, and our team continue to actively look for new opportunities to grow our business and technical capabilities."

Β 

This announcement, released by Volex plc, contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

Β 

For further information please contact:

Β 

Volex plc

Β 

Nat Rothschild, Executive Chairman

Daren Morris, Group Chief Financial Officer

Β 

Tel: 020 8017 3240/07909 995 887

Liberum

Nominated Adviser & Broker

Β 

Steve Pearce

Euan Brown

Β 

Tel: 020 3100 2222

Β 

Β 

Whitman Howard

Joint Broker

Β 

Hugh Rich

Nick Lovering

Β 

Tel: 020 7659 1234

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
TSTSEDFWWFUSEDD
Date   Source Headline
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSDeferred Consideration for Acquisition
19th Dec 20247:00 amRNSForm 8.3 - Volex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.